0001663038false--07-31Q320251300000000.000010.000010.00001005000000500500falsefalsefalsefalse00016630382024-08-012025-04-300001663038us-gaap:SeriesAPreferredStockMember2024-08-012025-04-300001663038us-gaap:SeriesBPreferredStockMember2024-08-012025-04-3000016630382023-03-012023-03-3100016630382023-02-210001663038relia:TopMember2023-02-210001663038relia:BottomMember2023-02-2100016630382023-07-012023-07-1700016630382023-07-012023-07-2500016630382024-09-012024-09-1200016630382021-06-012021-06-140001663038relia:AprilThirtyTwoThousandTwentyFiveMember2024-07-310001663038relia:MarchFourTwoThousandTwentyFiveMember2024-07-310001663038relia:AugustSixteenTwoThousandTwentyFourMember2024-07-310001663038relia:FebruaryElevenTwoThousandTwentyFiveMember2024-07-310001663038relia:DecemberSevenTwoThousandTwentyFourMember2024-07-310001663038relia:DecemberFiveTwoThousandTwentyFourMember2024-07-310001663038relia:OctoberTwentyNineTwoThousandTwentyFourOneMember2024-07-310001663038relia:OctoberTwentyNineTwoThousandTwentyFourMember2024-07-310001663038relia:OctoberTwentyEightTwoThousandTwentyFourMember2024-07-310001663038relia:SeptemberTwelveTwoThousandTwentyFourMember2024-07-310001663038relia:AugustTwoTwoThousandTwentyFourMember2024-07-310001663038relia:JuneTwentyFiveTwoThousandTwentyFourMember2024-07-310001663038relia:JuneSeventeenTwoThousandTwentyFourMember2024-07-310001663038relia:MayFiveTwoThousandTwentyFourMember2024-07-310001663038relia:AprilTwentyTwoTwoThousandTwentyFourMember2024-07-310001663038relia:AprilTwoTwoThousandTwentyFourMember2024-07-310001663038relia:MarchFourteenTwoThousandTwentyThreeMember2024-07-310001663038relia:AprilTwentyEighthTwoThousandTwentyThreeMember2024-07-310001663038relia:AprilTwentyEighthTwoThousandTwentyThreeOneMember2024-07-310001663038relia:MayFourTwoThousandTwentyThreeMember2024-07-310001663038relia:JulyThirtyOneTwoThousandTwentyThreeMember2024-07-310001663038relia:SeptemberEightTwoThousandTwentyThreeMember2024-07-310001663038relia:SeptemberElevenTwoThousandTwentyThreeMember2024-07-310001663038relia:SeptemberThirteenTwoThousandTwentyThreeMember2024-07-310001663038relia:SeptemberTwentyTwoThousandTwentyThreeMember2024-07-310001663038relia:SeptemberTwentyNineTwoThousandTwentyThreeMember2024-07-310001663038relia:OctoberElevenTwoThousandTwentyThreeMember2024-07-310001663038relia:OctoberSixteenTwoThousandTwentyThreeMember2024-07-310001663038relia:JanuaryThirtyOneTwoThousandTwentyFourMember2024-07-310001663038relia:FebruaryEightTwoThousandTwentyFourMember2024-07-310001663038relia:FebruaryTwentyOneTwoThousandTwentyFourMember2024-07-310001663038relia:FebruaryTwentyTwoTwoThousandTwentyFourMember2024-07-310001663038relia:FebruaryTwentyEightTwoThousandTwentyFiveMember2024-07-310001663038relia:AprilThirtyTwoThousandTwentyFiveMember2025-04-300001663038relia:MarchFourTwoThousandTwentyFiveMember2025-04-300001663038relia:FebruaryTwentyEightTwoThousandTwentyFiveMember2025-04-300001663038relia:AugustSixteenTwoThousandTwentyFourMember2025-04-300001663038relia:FebruaryElevenTwoThousandTwentyFiveMember2025-04-300001663038relia:DecemberSevenTwoThousandTwentyFourMember2025-04-300001663038relia:DecemberFiveTwoThousandTwentyFourMember2025-04-300001663038relia:OctoberTwentyNineTwoThousandTwentyFourOneMember2025-04-300001663038relia:OctoberTwentyNineTwoThousandTwentyFourMember2025-04-300001663038relia:OctoberTwentyEightTwoThousandTwentyFourMember2025-04-300001663038relia:SeptemberTwelveTwoThousandTwentyFourMember2025-04-300001663038relia:AugustTwoTwoThousandTwentyFourMember2025-04-300001663038relia:JuneTwentyFiveTwoThousandTwentyFourMember2025-04-300001663038relia:JuneSeventeenTwoThousandTwentyFourMember2025-04-300001663038relia:MayFiveTwoThousandTwentyFourMember2025-04-300001663038relia:AprilTwentyTwoTwoThousandTwentyFourMember2025-04-300001663038relia:AprilTwoTwoThousandTwentyFourMember2025-04-300001663038relia:MarchFourteenTwoThousandTwentyThreeMember2025-04-300001663038relia:AprilTwentyEighthTwoThousandTwentyThreeMember2025-04-300001663038relia:AprilTwentyEighthTwoThousandTwentyThreeOneMember2025-04-300001663038relia:MayFourTwoThousandTwentyThreeMember2025-04-300001663038relia:JulyThirtyOneTwoThousandTwentyThreeMember2025-04-300001663038relia:SeptemberEightTwoThousandTwentyThreeMember2025-04-300001663038relia:SeptemberElevenTwoThousandTwentyThreeMember2025-04-300001663038relia:SeptemberThirteenTwoThousandTwentyThreeMember2025-04-300001663038relia:SeptemberTwentyTwoThousandTwentyThreeMember2025-04-300001663038relia:SeptemberTwentyNineTwoThousandTwentyThreeMember2025-04-300001663038relia:OctoberElevenTwoThousandTwentyThreeMember2025-04-300001663038relia:OctoberSixteenTwoThousandTwentyThreeMember2025-04-300001663038relia:JanuaryThirtyOneTwoThousandTwentyFourMember2025-04-300001663038relia:FebruaryEightTwoThousandTwentyFourMember2025-04-300001663038relia:FebruaryTwentyOneTwoThousandTwentyFourMember2025-04-300001663038relia:FebruaryTwentyTwoTwoThousandTwentyFourMember2025-04-300001663038relia:FebruaryTenTwoThousandTwentyThreeOneMember2024-07-310001663038relia:FebruaryTenTwoThousandTwentyThreeMember2024-07-310001663038relia:JulyTwentyTwoThousandTwentyOneMember2024-07-310001663038relia:JulyTwentyTwoThousandTwentyOneMember2025-04-300001663038relia:FebruaryTenTwoThousandTwentyThreeMember2025-04-300001663038relia:FebruaryTenTwoThousandTwentyThreeOneMember2025-04-300001663038relia:JuneFourteenTwoThousandTwentyOneMember2025-04-300001663038relia:JuneFourteenTwoThousandTwentyOneMember2024-07-310001663038us-gaap:RetainedEarningsMember2025-04-300001663038relia:StockPayableMember2025-04-300001663038us-gaap:AdditionalPaidInCapitalMember2025-04-300001663038us-gaap:CommonStockMember2025-04-300001663038relia:SeriesBPreferredSharesMember2025-04-300001663038us-gaap:RetainedEarningsMember2025-02-012025-04-300001663038us-gaap:AdditionalPaidInCapitalMember2025-02-012025-04-300001663038us-gaap:CommonStockMember2025-02-012025-04-3000016630382025-01-310001663038us-gaap:RetainedEarningsMember2025-01-310001663038relia:StockPayableMember2025-01-310001663038us-gaap:AdditionalPaidInCapitalMember2025-01-310001663038us-gaap:CommonStockMember2025-01-310001663038relia:SeriesBPreferredSharesMember2025-01-3100016630382024-11-012025-01-310001663038us-gaap:RetainedEarningsMember2024-11-012025-01-310001663038relia:StockPayableMember2024-11-012025-01-310001663038us-gaap:AdditionalPaidInCapitalMember2024-11-012025-01-310001663038us-gaap:CommonStockMember2024-11-012025-01-310001663038relia:SeriesBPreferredSharesMember2024-11-012025-01-3100016630382024-10-310001663038us-gaap:RetainedEarningsMember2024-10-310001663038relia:StockPayableMember2024-10-310001663038us-gaap:AdditionalPaidInCapitalMember2024-10-310001663038us-gaap:CommonStockMember2024-10-310001663038relia:SeriesBPreferredSharesMember2024-10-3100016630382024-08-012024-10-310001663038us-gaap:RetainedEarningsMember2024-08-012024-10-310001663038relia:StockPayableMember2024-08-012024-10-310001663038us-gaap:AdditionalPaidInCapitalMember2024-08-012024-10-310001663038us-gaap:CommonStockMember2024-08-012024-10-310001663038relia:SeriesBPreferredSharesMember2024-08-012024-10-310001663038us-gaap:RetainedEarningsMember2024-07-310001663038relia:StockPayableMember2024-07-310001663038us-gaap:AdditionalPaidInCapitalMember2024-07-310001663038us-gaap:CommonStockMember2024-07-310001663038relia:SeriesBPreferredSharesMember2024-07-3100016630382024-04-300001663038us-gaap:RetainedEarningsMember2024-04-300001663038relia:StockPayableMember2024-04-300001663038us-gaap:AdditionalPaidInCapitalMember2024-04-300001663038us-gaap:CommonStockMember2024-04-300001663038relia:SeriesBPreferredSharesMember2024-04-300001663038us-gaap:RetainedEarningsMember2024-02-012024-04-300001663038relia:StockPayableMember2024-02-012024-04-300001663038us-gaap:AdditionalPaidInCapitalMember2024-02-012024-04-300001663038us-gaap:CommonStockMember2024-02-012024-04-300001663038relia:SeriesBPreferredSharesMember2024-02-012024-04-3000016630382024-01-310001663038us-gaap:RetainedEarningsMember2024-01-310001663038relia:StockPayableMember2024-01-310001663038us-gaap:AdditionalPaidInCapitalMember2024-01-310001663038us-gaap:CommonStockMember2024-01-310001663038relia:SeriesBPreferredSharesMember2024-01-3100016630382023-11-012024-01-310001663038us-gaap:RetainedEarningsMember2023-11-012024-01-310001663038relia:StockPayableMember2023-11-012024-01-310001663038us-gaap:AdditionalPaidInCapitalMember2023-11-012024-01-310001663038us-gaap:CommonStockMember2023-11-012024-01-310001663038relia:SeriesBPreferredSharesMember2023-11-012024-01-3100016630382023-10-310001663038us-gaap:RetainedEarningsMember2023-10-310001663038relia:StockPayableMember2023-10-310001663038us-gaap:AdditionalPaidInCapitalMember2023-10-310001663038us-gaap:CommonStockMember2023-10-310001663038relia:SeriesBPreferredSharesMember2023-10-3100016630382023-08-012023-10-310001663038us-gaap:RetainedEarningsMember2023-08-012023-10-310001663038relia:StockPayableMember2023-08-012023-10-310001663038us-gaap:AdditionalPaidInCapitalMember2023-08-012023-10-310001663038us-gaap:CommonStockMember2023-08-012023-10-310001663038relia:SeriesBPreferredSharesMember2023-08-012023-10-3100016630382023-07-310001663038us-gaap:RetainedEarningsMember2023-07-310001663038relia:StockPayableMember2023-07-310001663038us-gaap:AdditionalPaidInCapitalMember2023-07-310001663038us-gaap:CommonStockMember2023-07-310001663038relia:SeriesBPreferredSharesMember2023-07-3100016630382023-08-012024-04-3000016630382024-02-012024-04-3000016630382025-02-012025-04-300001663038us-gaap:SeriesBPreferredStockMember2024-07-310001663038us-gaap:SeriesBPreferredStockMember2025-04-300001663038us-gaap:SeriesAPreferredStockMember2024-07-310001663038us-gaap:SeriesAPreferredStockMember2025-04-300001663038relia:SeriesPreferredStockMember2024-07-310001663038relia:SeriesPreferredStockMember2025-04-3000016630382024-07-3100016630382025-04-3000016630382025-06-19iso4217:USDxbrli:sharesiso4217:USDxbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

~~x QUARTERLY REPORT UNDER SECTION 13 OR 15~~(d)Mark ~~OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED APRIL 30, 2018~~One)

~~Commission~~☒ ~~file~~QUARTERLY ~~number~~REPORT ~~333-208934~~PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

~~RELIANT~~For ~~SERVICE~~the ~~INC.~~Quarterly ~~(Exact~~Period ~~name~~Ended: April of30, ~~registrant as specified in its charter)~~2025

~~Nevada~~ OR

~~(State~~☐ orTRANSITION ~~other~~REPORT ~~jurisdiction~~PURSUANT ofTO ~~incorporation~~SECTION or13 ~~organization~~OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

3For ~~Rabí,~~the ~~Rabí,~~Transition ~~Czech~~Period ~~Republic~~From ~~34201~~____________ to ____________.

~~reliantservices@inbox~~QUANTUMZYME CORP.lv (Exact name of registrant as specified in its charter)

(Address of principal executive offices, including zip code.)

Nevada

000-56725

N/A

(State or other jurisdiction

of Incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

~~Telephone~~15656 ~~(702)442-0901~~Bernardo Center Drive Suite 801

~~(Telephone~~San ~~number~~Diego, ~~including~~CA ~~area code)~~92127

~~Check whether the issuer~~ (1)Address ~~filed all reports required to be filed by Section 13 or 15(d)~~ of ~~the~~principal ~~Exchange~~executive ~~Act during the past 12 months (or for such shorter period that the registrant was required to file such reports~~offices)~~, and (2) has been subject to such filing requirements for the last 90 days. YES x NO ¨~~

~~Indicate~~Tel: by+1 check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S858-~~T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES x NO ¨~~203-0312

~~Indicate~~(Registrant’s bytelephone ~~check mark whether the registrant is a large accelerated filer~~number, anincluding ~~accelerated~~area filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer, "accelerated filer," "non-accelerated filer," and "smaller reporting company" in Rule 12b-2 of the Exchange Act.code)

~~Large~~Securities ~~accelerated~~registered ~~filer~~under ¨Section ~~Accelerated~~12(b) ~~filer~~of ¨the ~~Non-accelerated filer ¨ Smaller reporting company x~~Act: None

Indicate by check mark whether the registrant is(1) ahas ~~shell~~filed ~~company~~all ~~(as~~reports ~~defined~~required into ~~Rule~~be ~~12b-2~~filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports)., ~~YES ¨~~and NO(2) xhas been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

~~State~~ Indicate by check mark whether the ~~number~~registrant ofhas ~~shares~~submitted ~~outstanding~~electronically ofevery ~~each~~Interactive ofData ~~the~~File ~~issuer's~~required ~~classes~~to be submitted pursuant to Rule 405 of ~~common~~Regulation ~~equity,~~S-T as(§232.405 of this chapter) during the ~~latest~~preceding ~~practicable~~12 ~~date:~~months ~~5,015,000~~(or ~~shares~~for assuch ofshorter ~~May~~period 7,that ~~2018~~the registrant was required to submit such files). Yes ☒ No ☐

~~PART~~Indicate Iby check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

~~FINANCIAL~~Large ~~INFORMATION~~accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☒ Emerging growth company ☒

~~ITEM~~If 1.an ~~FINANCIAL~~emerging ~~STATEMENTS~~growth company, indicate by check mark if the Company has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☒

RELIANT SERVICE INC
(A Development Stage Company)
Balance Sheet
	For the			For the
	Nine Months Ended			Year Ended
	April 30, 2018			July 31, 2017
	(Unaudited)			(Audited)
ASSETS
Current Assets
Cash (USD)	$	486		$	2,744
Income Tax Benefit		5,190			4,704
Total Current Assets		5,676			7,448
Fixed Assets
Czech Office Building		11,900			11,900
Less Accumulated Depreciation		(1,740	)		(1,305	)
Total Fixed Assets		10,160			10,595
Total Assets	$	15,836		$	18,043
LIABILITIES & STOCKHOLDERS' EQUITY
Current Liabilities
Loan Payable - Related Party	$	100		$	100
Total Current Liabilities		100			100
Stockholders' Equity
Common stock, ($0.001 par value, 75,000,000 shares authorized; 5,015,000 shares issued and outstanding as of April 30, 2018 and July 31, 2017	$	5,015		$	5,015
Additional Paid-In Capital		39,585			39,585
Net profit (loss) accumulated during development stage		(28,864	)		(26,657	)
Total Stockholders' Equity		15,736			17,943
Total Liabilities & Stockholders' Equity	$	15,836		$	18,043

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

2Yes ☐ No ☒

RELIANT SERVICE INC
(A Development Stage Company)
Statement of Operations (Unaudited)
													From Inception
	For the			For the			For the			For the			(March 20,
	Three Months Ended			Three Months Ended			Nine Months Ended			Nine Months Ended			2015) Through
	April 30, 2018			April 30, 2017			April 30, 2018			April 30, 2017			April 30, 2018
Revenues
Merchandise Sales	$	31,108		$	41,897		$	93,550		$	108,912		$	373,139
Cost of Goods Sold		29,007			27,798			89,345			87,630			317,308
Gross Profit		2,101			14,099			4,205			21,282			55,831
Expenses
General and Administration		1,765			2,226			6,462			21,352			53,539
Depreciation		145			145			435			435			1,740
Private Label Development		-			-			-			38,700			38,700
Total Expenses		1,910			2,371			6,897			60,487			93,979
Income Before Income Taxes		191			11,728			(2,692	)		(39,205	)		(38,149	)
Income Tax Benefit (Provision)		(29	)		(1,759	)		404			5,881			9,285
Net Income	$	162		$	9,969		$	(2,288	)	$	(33,324	)	$	(28,864	)
Net Income (loss) Per Basic and Diluted share		0.0000			0.0020			(0.0005	)		(0.0066	)		(0.0058	)
Weighted average number of Common Shares outstanding		5,015,000			5,015,000			5,015,000			5,015,000			5,015,000

As of June 20, 2025, the registrant had 38,962,050 shares of common stock issued and outstanding.

3QUANTUMZYME CORP.

RELIANT SERVICE INC
(A Development Stage Company)
Statement of Cash Flows (Unaudited)
							From Inception
	For the			For the			(March 20,
	Nine Months Ended			Nine Months Ended			2015) Through
	April 30, 2018			April 30, 2017			April 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$	(2,288	)	$	(33,324	)	$	(28,864	)
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Income Tax Benefit (Payable)		(404	)		(5,881	)		(5,190	)
Accounts Payable		-			-			-
Depreciation		435			435			1,740
Changes in operating assets and liabilities:
		-			-			-
Net cash provided by (used in) operating activities		(2,257	)		(38,770	)		(32,314	)
CASH FLOWS FROM INVESTING ACTIVITIES
Czech Office Building		-			-			(11,900	)
Net cash provided by (used in) investing activities		-			-			(11,900	)
CASH FLOWS FROM FINANCING ACTIVITIES
Loan Payable - Related Party		-			-			100
Issuance of common stock		-			40,600			44,600
Net cash provided by (used in) financing activities		-			40,600			44,700
Net increase (decrease) in cash		(2,257	)		1,830			486
Cash at beginning of period		2,744			221			-
Cash at end of period	$	486		$	2,052		$	486
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid during year for:
Interest	$	-			-
Income Taxes	$	-			-

FORM 10-Q

4Index

RELIANT SERVICE INC

PART I. FINANCIAL INFORMATION

Item 1.	Condensed Financial Statements.	4
	CONDENSED BALANCE SHEETS	4
	CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED)	5
	CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY (UNAUDITED)	6
	CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED)	7
	NOTES TO CONDENSED FINANCIAL STATEMENTS (UNAUDITED)	8
Item 2.	Management’s Discussion and Analysis of Financial Conditions and Results of Operations.	14
Item 3.	Quantitative and Qualitative Disclosures about Market Risk.	17
Item 4.	Controls and Procedures.	17

PART II. OTHER INFORMATION

Item 1.	Legal Proceedings.	19
Item 1A.	Risk Factors.	19
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.	19
Item 3.	Defaults Upon Senior Securities.	19
Item 4.	Mine Safety Disclosures.	19
Item 5.	Other Information.	19
Item 6.	Exhibits.	20

(A2 ~~DEVELOPMENT~~Table ~~STAGE~~of ~~COMPANY)~~Contents

~~NOTES~~SPECIAL TONOTE ~~FINANCIAL~~REGARDING ~~STATEMENTS~~FORWARD-LOOKING INFORMATION

~~April~~This 30quarterly report on Form 10-Q and other publicly available documents, ~~2018~~including the documents incorporated herein by reference, contain, and our officers and representatives may from time to time make, “forward-looking” statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “believe,” “expect,” “future,” “likely,” “may,” “plan,” “seek,” “will” and similar references to future periods actions or results. Examples of forward-looking statements include our prospects for one or more future material transactions, potential sources of financing, and expenses for future periods.

~~NOTE~~Forward-looking 1 statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking ~~ORGANIZATION~~statements ~~AND~~relate ~~NATURE~~to OFthe ~~BUSINESS~~future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements.

~~Reliant~~Any ~~Service~~forward-looking ~~Inc.~~statement ~~(the~~made ~~“Company”)~~by ~~was~~us ~~incorporated~~ in ~~the~~this ~~state~~quarterly ofreport ~~Nevada~~ on ~~March~~Form ~~20,~~10-Q ~~2015.~~is ~~The~~based ~~company~~only ~~develops~~on ~~marketing~~information ~~channels~~currently available to ~~distribute~~us ~~office~~and ~~equipment~~speaks toonly as of the ~~wholesale~~date ~~market~~on inwhich ~~the~~it ~~United~~is ~~States~~made. ~~Our~~We ~~functional~~undertake ~~currency~~no isobligation ~~the~~to USpublicly ~~Dollar~~update ~~and~~any ~~all~~forward-looking ~~the~~statement, ~~references~~whether written or oral, that may be made from time to ~~currency~~time, inwhether ~~the~~as ~~financial~~a ~~statements~~result ~~are~~of innew USinformation, ~~Dollars~~future developments or otherwise.

~~The~~Factors ~~Company~~that iscould acause ~~development~~or ~~stage~~contribute ~~company~~to assuch ~~defined~~differences bymay include, but are not limited to, those described under the ~~Financial~~heading “Risk ~~Accounting~~Factors” which ~~Standards~~may ~~Board'~~be included in the Company’s ~~Accounting~~Registration ~~Standards~~Statement ~~Codification~~on ~~Topic~~Form ~~915~~10 ~~related~~as previously filed with the Securities and Exchange Commission. Readers are cautioned not to ~~Development~~place ~~Stage~~undue ~~Entities~~reliance on these forward-looking statements, which speak only as of the date of this report. The Company ~~qualifies~~undertakes asno aobligation ~~development~~to ~~stage~~revise ~~company~~any asforward-looking itstatements ~~has~~in ~~not~~order ~~generated~~to ~~significant~~reflect ~~revenues~~events ~~from~~or ~~operations~~circumstances that may subsequently arise. Readers are urged to carefully review and consider the various disclosures made by the Company in this report and in the Company’s other reports filed with the Commission that advise interested parties of the risks and factors that may affect the Company’s business.

~~Basis~~3 Table of ~~Presentation~~Contents

~~The~~PART ~~Company prepares its financial statements on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America (GAAP)~~I. FINANCIAL INFORMATION

~~NOTE~~Item ~~2 -~~1. ~~SUMMARY~~Condensed OFFinancial ~~SIGNIFICANT ACCOUNTING POLICIES~~Statements.

~~This~~QUANTUMZYME ~~summary of significant accounting policies is presented to assist in understanding these financial statements~~CORP. ~~The financial statements and notes are representations of management, who is responsible for their integrity and objectivity.~~

~~Use~~(FORMALLY ofRELIANT ~~Estimates~~SERVICES, INC.)

~~The~~ CONDENSED ~~preparation~~BALANCE of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.SHEETS

Cash

	April 30, 2025			July 31, 2024
	(Unaudited)
ASSETS

Cash	$	584		$	-
Prepaid expenses		-			10,000
Total current assets		584			10,000

Total assets	$	584		$	10,000

LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities
Accounts payable and accrued expenses	$	145,672		$	109,780
Due to related parties		17,002			15,852
Notes payable		240,451			167,666
Total current liabilities		403,125			293,298

Total liabilities		403,125			293,298

Commitments and Contingencies (See note 5)		-			-

Preferred Shares 130,000,000 authorized shares, par value $0.00001 0 shares issued and outstanding as of April 30, 2025 and July 31, 2024, respectively		-			-
Series A Preferred Shares 10,000,000 authorized shares, par value $0.00001 0 shares issued and outstanding as of April 30, 2025 and July 31, 2024, respectively		-			-
Series B Preferred Shares 10,000,000 authorized shares, par value $0.00001 500 shares issued and outstanding as of April 30, 2025 and July 31, 2024, respectively		5			5
Common Shares 750,000,000 authorized shares, par value $0.00001; 38,962,050 and 34,777,050 shares issued and outstanding as of April 30, 2025 and July 31, 2024 , respectively		388			347
Additional paid-in capital		5,195,456			5,153,648
Accumulated deficit		(5,598,390	)		(5,437,298	)
Total stockholders' deficit		(402,541	)		(283,298	)

Total liabilities and stockholders' deficit	$	584		$	10,000

The ~~Company~~accompanying ~~considers~~notes ~~all~~are ~~cash~~an ~~balances~~integral onpart ~~deposit~~of ~~with~~these unaudited financial ~~institutions and highly liquid investments with a maturity of three months or less to be cash equivalents~~statements.

~~Property~~4 ~~and~~Table ~~Equipment~~of Contents

~~Property~~QUANTUMZYME ~~and equipment is stated at cost less accumulated depreciation~~CORP. ~~Depreciation is computed using the straight-line method over estimated useful lives listed below:~~

~~Estimated~~(FORMALLY ~~Useful~~RELIANT ~~Life~~SERVICES, ~~Buildings 15 years~~INC.)

5CONDENSED STATMENTS OF OPERATIONS

~~RELIANT SERVICE INC~~(Unaudited)

(A DEVELOPMENT STAGE COMPANY)

	For the three months ended						For the nine months ended
	April 30						April 30
	2025			2024			2025			2024

Sales	$	-		$	-		$	-		$	-

Operating expenses
General and administrative		11,453			7,772			16,365			30,177
Professional fees		49,000			52,500			129,556			96,221
Total operating expenses		60,453			60,272			145,921			126,398

Loss from operations		(60,453	)		(60,272	)		(145,921	)		(126,398	)

Other expense
Interest expense		(5,310	)		(3,590	)		(15,171	)		(10,943	)
Total other expenses		(5,310	)		(3,590	)		(15,171	)		(10,943	)

Net loss before tax provision		(65,763	)		(63,862	)		(161,092	)		(137,341	)
Tax provision		-			-			-			-
Net loss	$	(65,763	)	$	(63,862	)	$	(161,092	)	$	(137,341	)

Net loss per common share: basic and diluted	$	(0.00	)	$	(0.00	)	$	(0.00	)	$	(0.00	)
Weighted average common shares outstanding -
basic and diluted		35,327,050			34,777,050			35,117,811			34,742,014

~~NOTES~~The TOaccompanying ~~FINANCIAL~~notes ~~STATEMENTS~~are an integral part of these unaudited financial statements.

~~April~~5 ~~30,~~Table ~~2018~~of Contents

~~Property~~QUANTUMZYME CORP.

~~The~~(FORMALLY ~~Company’s~~RELIANT ~~principal offices are located at 3 Rabi~~SERVICES, ~~Rabi, Czech Republic, 34201~~INC. ~~The property was purchased on July 30, 2015 for $11,900.~~)

~~Income~~STATEMENTS ~~Taxes~~OF STOCKHOLDERS' DEFICIT

We account for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, we determine deferred tax assets and liabilities on the basis of the differences between the financial statement and tax bases of the asset and liabilities by using enacted tax rates in effect for the year in which the differences are expected to reverse. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.(Unaudited)

We recognize deferred tax assets to the extent that we believe that these assets are more likely than not to be realized. In making such a determination, we consider all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies and results of recent operations. If we determine that we would be able to realize our deferred tax assets in the future in excess of their net recorded amount, we would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.

	Series B
	Preferred				Common				Paid-In		Stock			Accumulated			Stockholders'
	Shares		Par Value		Shares		Par Value		Capital		Payable			Deficit			Deficit

Balance, July 31, 2024		500		5		34,777,050		347		5,153,648		-			(5,437,298	)		(283,298	)
Shares issued for cash		-		-		550,000		6		5,494		-			-			5,500
Net loss		-		-		-		-		-		-			(65,523	)		(65,523	)
Balance, October 31, 2024		500		5		35,327,050		353		5,159,142		-			(5,502,821	)		(343,322	)
Net loss		-		-		-		-		-		-			(29,806	)		(29,806	)
Balance, January 31, 2025		500		5		35,327,050		353		5,159,142		-			(5,532,627	)		(373,128	)
Shares issued for cash						3,635,000		36		36,314								36,350
Net loss															(65,763	)		(65,763	)
Balance, April 30, 2025		500		5		38,962,050		389		5,195,456		-			(5,598,390	)		(402,541	)


Balance, July 31, 2023		500		5		31,577,050		315		5,096,280		3,200			(197,029	)		4,902,771
Share to be issued for settlement of notes payable		-		-		3,200,000		32		3,168		(3,200	)		-			-
Net loss		-		-		-		-		-		-			(67,498	)		(67,498	)
Balance, October 31, 2023		500		5		34,777,050		347		5,099,448		-			(264,527	)		4,835,273
Net loss		-		-		-		-		-		-			(5,981	)		(5,981	)
Balance, January 31, 2024		500		5		34,777,050		347		5,099,448		-			(270,508	)		4,829,292
Net loss		-		-		-		-		-		-			(63,862	)		(63,862	)
Balance, April 30, 2024		500		5		34,777,050		347		5,099,448		-			(334,370	)		4,765,430

WeThe ~~record~~accompanying ~~uncertain~~notes ~~tax~~are ~~positions~~an inintegral ~~accordance~~part ~~with ASC 740 on the basis~~ of athese ~~two-step~~unaudited financial process in which (1) we determine whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition thresholdstatements. ~~We recognize the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority.~~

~~Revenue~~6 ~~Recognition~~Table of Contents

~~The~~QUANTUMZYME Company recognizes revenues and the related costs when persuasive evidence of an arrangement exists, delivery and acceptance has occurred, the price is fixed or determinable, and collection of any resulting receivable is reasonably assuredCORP. Costs and expenses are recognized during the period in which they are incurred. Any revenues earned are from the sales of office equipment. The Company recognizes these sales once delivery time is confirmed by the customer.

~~All~~(FORMALLY ~~revenue~~RELIANT ~~generated~~SERVICES, ~~by the Company to date has been generated from U~~INC.~~S. sales and deposited to our U.S. bank account.~~)

6CASH FLOWS

~~RELIANT SERVICE INC~~(Unaudited)

(A DEVELOPMENT STAGE COMPANY)

	For the nine months ended
	April 30, 2025			April 30, 2024
Cash Flows from Operating Activities
Net loss	$	(161,092	)	$	(137,341	)
Adjustments to reconcile net loss to net cash provided by operating activities:
Forgiveness of note payable		(2,500	)
Changes in assets and liabilities
Prepaid expenses		10,000			-
Accounts payable		35,892			43,214
Due to related party		1,150			5,940
Net cash from operating activities		(116,550	)		(88,187	)

Cash Flows from Financing Activities
Proceeds from the issuance of common stock		41,850			-
Proceeds from notes payable		75,284			88,187
Net cash from financing activities		117,134			88,187

Net increase in cash		584			-
Cash, beginning of period		-			-
Cash, end of period	$	584		$	-

Supplemental disclosure of cash flow information
Cash paid for interest	$	-		$	-
Cash paid for taxes	$	-		$	-

SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:

Share to be issued for settlement of notes payable	$	-		$	3,200

~~NOTES~~The TOaccompanying ~~FINANCIAL~~notes ~~STATEMENTS~~are an integral part of these unaudited financial statements.

~~April~~7 ~~30,~~Table ~~2018~~of Contents

~~NOTE~~QUANTUMZYME ~~3 - GOING CONCERN~~CORP

~~The~~(FORMALLY ~~accompanying~~RELIANT ~~financial~~SERVICES, ~~statements and notes have been prepared assuming that the Company will continue as a going concern~~INC.)

~~For~~NOTES ~~the~~TO ~~three~~CONDENSED FINANCIAL and nine-month periods ended April 30, 2018, the Company had a net gain (loss) of $162 and $(2,288), respectively. The Company’s ability to continue as a going concern is dependent upon the Company’s ability to generate sufficient revenues to operate profitably or raise additional capital through debt financing and/or through sales of common stock.STATEMENTS

~~Management~~April ~~has~~30, funded operations of the Company through the proceeds from an offering pursuant to a Registration Statement on Form S-1 and may raise funds from private placements of restricted securities or the issuance of stock in lieu of cash for payment of services until such time as profitable operations are achieved. 2025

~~There~~NOTE ~~are~~1 no– ~~written~~NATURE ~~agreements~~OF inBUSINESS ~~place~~AND for such funding or issuance of securities and there can be no assurance that such will be available in the future. Management believes that this plan provides an opportunity for the Company to continue as a going concern.OPERATIONS

~~The~~Organization ~~failure to achieve the necessary levels of profitability or obtain the additional funding would be detrimental to the Company.~~

~~NOTE~~Quantumzyme 4Corp. -(formally ~~RECENT~~Reliant ~~ACCOUNTING~~Service ~~PRONOUNCEMENTS~~Inc.) (the “Company”) was incorporated in the state of Nevada on March 20, 2015. The company develops marketing channels to distribute office equipment to the wholesale market in the United States. Our functional currency is the US Dollar and all the references to currency in the financial statements are in US Dollars.

~~Recent~~On ~~Accounting~~February ~~Pronouncements~~8, 2023, Ms. Sandra (Demeria) Brossart (“Brossart”) resigned as the sole-officer and director of the Company, and Mr. Naveen Krishna Rao Kulkarni (“Kulkarni”) was appointed as sole-officer and director in her place. Thereafter, on February 21, 2023, the Company entered into that certain Asset Purchase Agreement (“Purchase Agreement”), between the Company and Quantumzyme Inc., a Delaware corporation, (“Quantumzyme”) and Kulkarni, the sole- officer, director, and shareholder of Quantumzyme (collectively, Quantumzyme and Mr. Kulkarni are hereinafter referred to as the “Seller”) pursuant to which the Company acquired various assets from the Seller, such assets are applied to and used in the “Enzyme Catalyst” biotransformation sector. In exchange for the Acquired Assets, the Company issued Mr. Kulkarni One Million Five Hundred (1,500,000) restricted shares of the Company’s common stock (Post split), representing approximately Seventy-Three (73%) percent of the Company’s issued and outstanding shares.

InOn ~~June~~March ~~2014~~31, ~~the FASB issued Accounting Standards Update ("ASU") No. 2014- 10 ("ASU2014-10")~~2023, Development Stage Entities (Topic 915), Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation. The objective of the ~~amendments~~Company inchanged ~~this~~its ~~Update~~name is to ~~improve~~Quantumzyme ~~financial reporting by reducing the cost and complexity associated with incremental reporting requirements for development stage entities~~Corp. The amendments in this Update also eliminate an exception provided to development stage entities in Topic 810, Consolidation, for determining whether an entity is a variable interest entity on the basis of the amount of investment equity at risk. The amendments related to the elimination of inception-to-date information and the other remaining disclosure requirements of Topic 915 should be applied retrospectively except for the clarification to Topic 275, which shall be applied prospectively.

~~These~~NOTE ~~amendments~~2 ~~are~~– ~~effective~~GOING for annual reporting periods beginning after December 15, 2014, and interim periods therein. The amendment eliminating the exception to the sufficiency-of-equity-at-risk criterion for development stage entities in paragraph 810-10-15-16 should be applied retrospectively for annual reporting periods beginning after December 15, 2015 and interim periods therein. Early application of each of the amendments is permitted for any annual reporting period or interim period for which the entity's financial statements have not yet been issued. The Company expects to adopt ASU 2014-10 in the fourth quarter of 2014 and does not expect this adoption to have a material impact on its financial condition, results of operations or cash flows.CONCERN

7The accompanying financial statements have been prepared in US dollars and in accordance with accounting principles generally accepted in the United States (“GAAP”) on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. During the nine months ended April 30, 2025, the Company incurred net losses of $161,092, accumulated deficits of $5,598,390, and used cash in operations in the amount of $116,550. These conditions raise substantial doubt about the Company's ability to continue as a going concern.

~~RELIANT~~We ~~SERVICE~~are ~~INC~~entirely dependent on our ability to attract and receive funding from either the sale of securities or outside sources such as private investment or a strategic partner. We currently have no firm agreements or arrangements with respect to any such financing and there can be no assurance that any needed funds will be available to us on acceptable terms or at all. The inability to obtain sufficient funding of our operations in the future will restrict our ability to grow and reduce our ability to continue to conduct business operations. Our failure to raise additional funds will adversely affect our business, and may require us to suspend our operations, which in turn may result in a loss to the purchasers of our common stock. If we are unable to obtain necessary financing, we will likely be required to curtail our development plans. Any additional equity financing may involve substantial dilution to our then existing stockholders.

(ANOTE ~~DEVELOPMENT~~3 ~~STAGE~~– ~~COMPANY)~~SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

~~NOTES~~Use TOof ~~FINANCIAL STATEMENTS~~ Estimates

~~April~~The ~~30,~~preparation ~~2018~~of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ significantly from those estimates.

~~NOTE~~8 4Table -of ~~RECENT ACCOUNTING PRONOUNCEMENTS - continued~~Contents

InCash August 2014, the FASB issued Accounting Standards Update ("ASU") No. 2014-15 ("ASU 2014-15"), Presentation of Financial Statements-Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern. The objective of the amendments in this Update is to provide guidance on determining when and ~~how~~Cash to disclose going-concern uncertainties in the financial statements. The new standard requires management to perform interim and annual assessments of an entity's ability to continue as a going concern within one year of the date the financial statements are issued. An entity must provide certain disclosures if "conditions or events raise substantial doubt about the entity's ability to continue as a going concern." The ASU applies to all entities and is effective for annual periods ending after December 15, 2016, and interim periods thereafter, with early adoption permitted. The Company is evaluating the impact of ASU 2014-15 on its financial condition, results of operations and cash flows.Equivalents

~~NOTE~~For ~~5 -~~purposes ~~PROPERTY~~of ~~AND~~the ~~EQUIPMENT~~statement of cash flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents to the extent the funds are not being held for investment purposes.

~~Property~~Stock-based ~~and equipment consists of the following:~~compensation

	4/30/2018			7/31/2017
Building	$	11,900		$	11,900
Less accumulated depreciation		(1,740	)		(1,305	)
	$	10,160		$	10,595

The Company records stock based compensation in accordance with the guidance in ASC Topic 505 and 718 which requires the Company to recognize expenses related to the fair value of its employee stock option awards. This eliminates accounting for share-based compensation transactions using intrinsic value and requires instead that such transactions be accounted for using a fair-value-based method. The Company recognizes the cost of all share-based awards on a graded vesting basis over the vesting period of the award.

~~Depreciation~~The ~~expense~~Company accounts for equity instruments issued in exchange for the ~~three~~receipt ~~months~~of ~~ended~~goods ~~April~~or ~~30,~~services ~~2018~~from ~~and~~other ~~2017~~than ~~was~~employees ~~$145~~in accordance with ASC 718-10 and ~~$145~~the conclusions reached by the ASC 505-50. Costs are measured at the estimated fair market value of the consideration received or the estimated fair value of the equity instruments issued, ~~respectively~~whichever is more reliably measurable. The value of equity instruments issued for consideration other than employee services is determined on the earliest of a performance commitment or completion of performance by the provider of goods or services as defined by ASC 505-50.

~~NOTE~~Concentration 6of -Credit ~~COMMON STOCK AND ISSUANCE~~Risk

The Company has ~~authorized~~no 75off-balance-sheet concentrations of credit risk such as foreign exchange contracts,~~000,000~~ ~~common~~options ~~shares~~contracts ator $0other foreign hedging arrangements.~~001par~~ ~~value,~~The Company maintains all of ~~which~~its ~~5,015,000~~cash ~~shares~~balances ~~are~~with ~~issued~~two ~~and~~financial ~~outstanding~~institutions asin ofthe ~~April~~form ~~30,~~of ~~2018~~demand deposits.

~~4,000,000~~Loss ~~shares~~per ~~were issued to our sole director for $4,000 on July 17, 2015.~~Share

~~1,015,000~~The ~~shares~~Company ~~were~~follows ~~issued~~ASC Topic 260 to 31account ~~independent~~for ~~shareholders~~the onearnings ~~October~~per ~~28,~~share. ~~2016~~Basic ~~pursuant~~earnings toper ~~the~~common ~~company’s~~share ~~Registration~~(“EPS”) ~~Statement~~calculations onare ~~Form~~determined ~~S-1.~~by ~~The~~dividing ~~shares~~net ~~were~~income ~~issued~~by atthe aweighted ~~per~~average ~~share~~number ~~price~~of shares of $0common stock outstanding during the year.04 Diluted earnings per common share ~~for~~calculations ~~total~~are ~~proceeds~~determined by dividing net income by the weighted average number of ~~$40~~common shares and dilutive common share equivalents outstanding. During periods when common stock equivalents,~~600~~ if any, are anti-dilutive they are not considered in the computation.

8Revenue Recognition

~~RELIANT~~The ~~SERVICE~~Company ~~INC~~recognizes revenue from its contracts with customers in accordance with ASC 606 – Revenue from Contracts with Customers. The Company recognizes revenues when satisfying the performance obligation of the associated contract that reflects the consideration expected to be received based on the terms of the contract.

Revenue related to contracts with customers is evaluated utilizing the following steps: (Ai) ~~DEVELOPMENT~~Identify ~~STAGE~~the ~~COMPANY~~contract, or contracts, with a customer; (ii) Identify the performance obligations in the contract; (iii) Determine the transaction price; (iv) Allocate the transaction price to the performance obligations in the contract; (v) Recognize revenue when the Company satisfies a performance obligation.

~~NOTES~~9 TOTable ~~FINANCIAL~~of ~~STATEMENTS~~ Contents

~~April~~Fair ~~30,~~Value ~~2018~~of Financial Instruments

~~NOTE~~The 7Company measures fair value in accordance with ASC 820 - ~~DEBT~~Fair Value Measurements. ASC 820 defines fair value and establishes a three-level valuation hierarchy for disclosures of fair value measurements. ASC 820 establishes a framework for measuring fair value in generally accepted accounting principles, and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, ASC 820 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by ASC 820 are:

OnLevel ~~April~~1 ~~14,~~- ~~2015~~Inputs ~~the~~are ~~Director and President of the Company~~unadjusted, ~~made~~quoted ~~the~~prices ~~initial deposit to the Company bank account~~ in ~~the~~active ~~amount~~markets ~~$100~~for ~~and~~identical isassets ~~being~~or ~~carried~~liabilities asat athe ~~loan~~measurement ~~payable~~date. ~~The loan is non-interest bearing, unsecured and due upon demand.~~

~~NOTE~~Level 82 - ~~RELATED~~Inputs ~~PARTY~~(other ~~TRANSACTIONS~~than quoted market prices included in Level 1) are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument’s anticipated life.

OnLevel ~~July~~3 ~~17,~~- ~~2015,~~Inputs ~~4,000,000~~reflect ~~shares~~management’s best estimate of what market participants would use in pricing the ~~Company’s~~asset ~~common~~or ~~stock~~liability ~~were~~at ~~issued~~the measurement date. Consideration is given to ~~our~~the ~~sole~~risk ~~director~~inherent ~~for~~in ~~$4,000~~the valuation technique and the risk inherent in the inputs to the model. Valuation of instruments includes unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.

OnAs ~~April~~defined ~~14,~~by ~~2015~~ASC 820, the ~~Director~~fair ~~and~~value ~~President~~ of ~~the~~a ~~Company~~financial ~~made~~instrument is the ~~initial~~amount ~~deposit~~at towhich the ~~Company~~instrument ~~bank~~could ~~account~~be exchanged in ~~the~~a ~~amount~~current ~~$100.~~transaction ~~The~~between ~~loan~~willing isparties, ~~non-interest~~other ~~bearing~~than in a forced or liquidation sale, ~~unsecured~~which ~~and~~was ~~due~~further ~~upon~~clarified ~~demand~~as the price that would be received to sell an asset or paid to transfer a liability (“an exit price”) in an orderly transaction between market participants at the measurement date.

The ~~Company's~~reported ~~sole~~fair ~~officer~~values for financial instruments that use Level 2 and ~~director~~Level is3 ~~involved~~inputs into ~~other~~determine ~~business~~fair ~~activities~~value are based on a variety of factors and assumptions. Accordingly, certain fair values may not represent actual values of the Company’s financial instruments that could have been realized as of April 30, 2025 and July 31, 2024 or that will be recognized in the future, ~~become~~and ~~involved~~do not include expenses that could be incurred in ~~other~~an ~~business~~actual ~~opportunities~~settlement. The carrying amounts of the Company’s financial assets and liabilities, such as ~~they~~cash, ~~become~~accounts payable and accrued expenses, and related party and third-party notes payables approximate fair value due to their relatively short maturities. The Company’s notes payable approximates the fair value of such instrument based upon management’s best estimate of terms that would be available to the Company for similar financial arrangements at April 30, 2025 and July 31, 2024.

~~NOTE~~Recent ~~9 -~~Accounting ~~FAIR VALUE MEASUREMENTS AND DISCLOSURE~~Pronouncements

~~FASB~~In ~~ASC~~November ~~820~~2023, ~~defines~~the ~~fair~~FASB ~~value~~issued ASU 2023-07, ~~establishes~~Segment aReporting ~~framework~~(Topic ~~for~~280): ~~measuring~~Improvements ~~fair~~to ~~value~~Reportable Segment Disclosures. The amendments in this ASU require disclosures, ~~and~~on ~~establishes~~an aannual ~~hierarchy~~and interim basis, of ~~fair~~significant ~~value~~segment ~~inputs.~~expenses ~~Fair~~that ~~value~~are isregularly provided to the ~~price~~chief ~~that~~operating ~~would~~decision bemaker ~~received~~(“CODM”), toas ~~sell~~well anas ~~asset~~the aggregate amount of other segment items included in the reported measure of segment profit or ~~paid~~loss. toThis ~~transfer~~ASU requires that a ~~liability~~public inentity disclose the title and position of the CODM and an ~~orderly~~explanation ~~transaction~~of ~~between~~how ~~market~~the ~~participants~~CODM atuses the ~~measurement~~reported ~~date.~~measure(s) Aof ~~fair~~segment ~~value~~profit ~~liability~~or ~~occurs~~loss in ~~the~~assessing ~~principal~~segment ~~market~~performance and deciding how to allocate resources. This ASU is effective for ~~the~~fiscal ~~asset~~years orbeginning ~~liability~~after orDecember 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The amendments in this ASU should be applied retrospectively to all prior periods presented in the ~~absence~~financial ofstatements. The Company adopted the ASU and determined that its adoption did not have a ~~principal~~material ~~market,~~impact on the ~~most~~Company’s ~~advantageous~~consolidated ~~market~~financial statements and related disclosures. ~~Valuation~~As ~~techniques~~defined ~~that~~in the ASU, operating segments are ~~consistent~~components ~~with~~of an enterprise about which discrete financial information is regularly provided to the ~~market,~~CODM ~~income~~in ormaking ~~cost~~decisions ~~approach,~~on how to allocate resources and assess performance for the organization. The Company operates and manages its business as ~~specified~~one byreportable ~~FASB~~and ~~ASC~~operating ~~820,~~segment. ~~are~~The ~~used~~Company’s CODM is the Chief Executive Officer. The Company’s CODM reviews consolidated operating results to ~~measure~~make ~~fair~~decisions ~~value~~about allocating resources and assessing performance for the entire Company.

The ~~fair~~Company ~~value~~does ~~hierarchy~~not ~~prioritized~~believe ~~the~~that ~~inputs~~other tostandards, ~~valuation~~which ~~techniques~~have ~~used~~been toissued ~~measure~~but ~~fair~~are ~~value~~not ~~into~~yet ~~three~~effective, ~~broad~~will ~~levels:~~have a significant impact on its financial statements.

~~Level~~10 ITable ~~inputs~~of ~~are quoted prices (unadjusted) in active markets for identical assets or liabilities the Company has the ability to access.~~Contents

~~Level~~NOTE 4 II– ~~inputs~~PROMISSORY ~~are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.~~NOTES

~~Level~~Promissory ~~III~~notes ~~are~~payable ~~unobservable~~as ~~inputs~~of ~~for~~April ~~the~~30, ~~asset~~2025 ~~or liability~~ and ~~rely~~July on31, ~~management’s~~2024 ~~own~~consists ~~assumptions~~of ~~that market participants would use in pricing~~ the ~~asset or liability. The unobservable inputs should be developed based on the best information available in the circumstances and may include the Company’s own data.~~following:

As of April 30, 2018, and 2017, there were no level I, II, or III assets or liabilities.

	April 30, 2025		July 31, 2024
Dated June 14, 2021	$	6,000	$	6,000
Dated July 20, 2021		642		642
Dated February 10, 2023		15,300		15,300
Dated February 10, 2023		12,750		12,750
Dated March 14, 2023		6,161		6,161
Dated April 28, 2023		7,803		7,803
Dated April 28, 2023		8,077		8,077
Dated May 4, 2023		5,904		5,904
Dated July 31, 2023		3,392		3,392
Dated September 8, 2023		2,000		2,000
Dated September 11, 2023		2,500		2,500
Dated September 13, 2023		6,000		6,000
Dated September 20, 2023		2,000		2,000
Dated September 29, 2023		20,000		20,000
Dated October 11, 2023		25,000		25,000
Dated October 16, 2023		6,000		6,000
January 31, 2024		1,420		1,420
February 8, 2024		7,500		7,500
February 21, 2024		7,000		7,000
February 22, 2024		1,865		1,865
April 2, 2024		1,902		1,902
April 22, 2024		5,000		5,000
May 5, 2024		450		450
June 17, 2024		3,000		3,000
June 25, 2024		10,000		10,000
August 2, 2024		6,000		-
August 16, 2024		3,125		-
September 12, 2024		1,500		-
October 28, 2024		10,000		-
October 29, 2024		5,000		-
October 29, 2024		6,500		-
December 5, 2024		8,000		-
December 7, 2024		3,190		-
February 11, 2025		2,500		-
February 28, 2025		8,300		-
March 4, 2025		4,500		-
April 30, 2025		14,169		-
Total notes payable	$	240,451	$	167,666

911 Table of Contents

~~RELIANT~~During ~~SERVICE~~the ~~INC~~nine months ended April 30, 2025 and 2024, the Company issued various promissory notes amounting to $75,284 and $64,920 for general operating purposes to one noteholder. The notes carry a 10% interest rate and are due upon 10 days written notice. As of April 30, 2025 and July 31 2024, the Company had amounts due to the note holder of $204,339 and $161,024, respectively.

(AOn ~~DEVELOPMENT~~June ~~STAGE~~14, ~~COMPANY)~~2021, the Company issued a promissory note for proceeds of $6,000. The note is due on demand and accrues interest at 10% per annum. On July 17, 2023, the note holder sold and assigned $3,200 of the balance to two unrelated parties. On July 25, 2023, the new note holders settled the combined balance of $3,200 for the issue of 3,200,000 shares of common stock valued at $3,200.

~~NOTES~~On TOSeptember ~~FINANCIAL~~12, ~~STATEMENTS~~2024, the Company issued two promissory notes for proceeds of $2,500. The notes carry a 10% interest rate and are due upon 10 days written notice. On November 30, 2024, the noteholders, forgave the balance of the notes for no consideration.

During the nine months ended April 30, ~~2018~~2025 and 2024, the Company recorded interest expense of $15,171 and $10,943, respectively.

NOTE 10 -5 ~~SUBSEQUENT~~– ~~EVENTS~~RELATED PARTY TRANSACTIONS

InAs ~~preparing~~of ~~these~~April ~~financial statements~~30, ~~the~~2025 ~~company~~and ~~has~~July ~~evaluated~~31, ~~events~~2024, ~~and~~the ~~transactions~~amount ~~for~~due ~~potential~~to ~~recognition~~related orparties ~~disclosure~~was ~~through~~$17,002 ~~May~~and 7$15, ~~2018~~852, ~~the~~respectively. ~~date~~Amounts ~~the~~due ~~financial~~to ~~statements~~related ~~were~~parties ~~issued. There~~ are nonon-interest ~~subsequent~~bearing ~~events~~and todue beon ~~reported~~demand.

NOTE 11 6 - ~~UNAUDITED~~COMMITMENTS ~~FINANCIAL~~AND ~~STATEMENTS~~CONTINGENCIES

~~The~~From ~~balance~~time ~~sheet~~to ~~as of April 30~~time, ~~2018 and~~ the ~~statements~~Company ofmay ~~operations~~become ~~and~~involved ~~cash~~in ~~flows~~various ~~for~~lawsuits ~~the three~~ and ~~nine-month~~legal ~~periods ended April 30~~proceedings, ~~2018~~which ~~have~~arise ~~been~~in ~~prepared by~~ the ~~Company~~ordinary ~~without~~course ~~audit, pursuant to the rules and regulations~~ of ~~the~~business. ~~Securities~~Litigation ~~and~~is ~~Exchange~~subject ~~Commission.~~to ~~Certain~~inherent ~~information~~uncertainties, and ~~footnote~~an ~~disclosures,~~adverse ~~normally~~result ~~included~~ in ~~the~~these ~~financial statements prepared in accordance with accounting principles generally accepted in the United States of America, have been condensed~~ or ~~omitted~~other asmatters ~~allowed~~may byarise ~~such~~from ~~rules~~time ~~and~~to ~~regulations,~~time ~~and the Company believes~~ that ~~the~~may ~~disclosures~~harm ~~are adequate to make the information presented not misleading~~business. ~~The~~Management ~~results~~is ofcurrently ~~operations for the three months ended April 30, 2018 are~~ not ~~necessarily~~aware ~~indicative~~ of ~~results~~any ~~expected~~such ~~for~~legal ~~the~~proceedings ~~full~~or ~~year~~claims ~~ending~~that ~~July~~could 31have, ~~2018.~~individually Inor in the ~~opinion of management~~aggregate, ~~all~~a ~~adjustments~~material ~~(which~~adverse ~~include~~effect ~~only~~on ~~normal~~our ~~recurring adjustments) necessary to present fairly the financial position~~business, ~~results of operations and changes in~~ financial ~~position at April 30~~condition, ~~2018~~or ~~have~~operating ~~been made~~results.

ItNOTE 7 is– ~~suggested~~STOCKHOLDERS’ ~~that these statements be read in conjunction with the July 31, 2017 and 2016 audited financial statements and the accompanying notes.~~EQUITY

10The Company’s authorized common stock consists of 750,000,000 shares with par value of $0.00001. As of April 30, 2025 and July 31, 2024, the Company had 38,962,050 and 34,777,050 shares of common stock issued and outstanding.

~~ITEM~~On 2February 21, 2023, the Company filed a Certificate of Amendment together with Amended & Restated Articles of Incorporation with the Secretary of State of the State of Nevada increasing the Company’s authorized shares of common stock from 75,000,000 to 900,000,000, consisting of 750,000,000 shares of Common Stock, par value $0.00001 ~~MANAGEMENT'S~~and ~~DISCUSSION~~150,000,000 ~~AND~~shares ~~ANALYSIS~~of ORauthorized ~~PLAN~~but OFundesignated ~~OPERATION~~preferred stock, par value $0.00001.

AOn ~~cautionary~~March ~~note~~31, ~~regarding~~2023, ~~forward-looking~~the Company’s Board of Directors approved a 1 to 100 reverse stock split as of the record date of March 31, 2023. As of the date of filing the reverse stock split has not been approved by FINRA. The financial statements have been retroactively restated to show the effect of the stock split.

~~This~~On ~~report~~May ~~contains~~24, ~~forward-looking statements which relate to future events or our future financial performance. In some cases~~2023, ~~you~~the ~~can~~Company ~~identify~~filed ~~forward-looking~~a ~~statements~~Certificate byof ~~terminology~~Designation ~~such as~~ (“~~may”,~~Certificate ~~“should”,~~of ~~“expects~~Designation”,) ~~“plans”,~~with ~~“anticipates”,~~the ~~“believes”,~~Secretary ~~“estimates”,~~of ~~“predicts”,~~State ~~“potential”~~of ~~or “continue” or~~ the ~~negative~~State of ~~these~~Nevada ~~terms~~that orprovided ~~other~~for ~~comparable~~the ~~terminology.~~creation ~~These~~of ~~statements~~Series ~~are~~A ~~only~~Preferred ~~predictions~~Stock and ~~involve~~Series ~~known~~B ~~and~~Preferred ~~unknown~~Stock ~~risks,~~from ~~uncertainties~~the ~~and~~previously ~~other~~authorized ~~factors~~but ~~that~~undesignated ~~may~~shares ~~cause~~of ~~our~~the ~~or our industry~~Company’s ~~actual~~preferred results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statementsstock.

~~While~~12 ~~these~~Table ~~forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction~~ of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggested herein. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results.Contents

~~Results~~The Company’s Certificate of ~~Operations~~Designation designates 10,000,000 shares as Series A Preferred Shares the designations, powers, preferences, rights, and restrictions granted or imposed upon the Series A Preferred Shares and holders thereof are as follows:

~~Three~~(i) ~~Months~~Series ~~Ended~~A ~~April~~Preferred ~~30,~~Stock ~~2018~~ranks senior to all other classes of stock; (ii) (ii) Series A Preferred Stock is convertible at a ratio of 1:10; and, ~~2017~~(iii) (iii) Series A Preferred Stock votes by multiplying the number of shares of Series A Preferred Stock held by such holder by 100.

~~We generated $31~~Additionally,~~108~~ ~~and $41,897 in revenues for~~ the ~~three~~Company’s ~~months~~Certificate ~~ending April 30, 2018 and 2017, respectively. Our cost~~ of ~~goods sold was $29~~Designation,~~007~~ ~~and~~designates ~~$27~~10,~~798~~000,000 ~~resulting~~shares inas aSeries ~~gross~~B ~~profit~~Preferred ofShares ~~$2,101~~the ~~and $14~~designations,~~099,~~ ~~respectively. The difference in the gross revenue was due to the type of cabinets purchased by the client. We incurred operating expenses of $1~~powers,~~910~~ ~~and $2~~preferences,~~371~~ ~~for the three months ended April 30~~rights, ~~2018~~ and ~~2017,~~restrictions ~~respectively.~~granted ~~These~~or ~~expenses~~imposed ~~consisted~~upon ~~of general operating expenses, including professional fees, incurred in connection with~~ the ~~day~~Series toB ~~day~~Preferred ~~operation~~Shares ~~of our business~~ and ~~the~~holders ~~preparation~~thereof ~~and~~are ~~filing~~as ~~of our periodic reports. An income tax provision of $29 was recorded for the three months ended April 30, 2018. An income tax benefit of $1,759 was recorded for April 30, 2017.~~ follows:

~~Nine~~(i) ~~Months~~Series ~~Ended~~B ~~April~~Preferred ~~30,~~Stock ~~2018~~ranks junior to all other classes of Preferred Stock; (ii) Series B Preferred Stock is convertible at a ratio of 1:50, and, ~~2017~~(iii) Series B Preferred Stock votes by multiplying the number of shares of Series B Preferred Stock held by such holder by 500.

WeDuring ~~generated $93,550 and $108,912 in revenues for the~~ nine months ending April 30, 2018 and 2017, respectively. Our cost of goods sold was $89,345 and $87,630, resulting in a gross profit of $4,205 and $21,282, respectively. The difference in the gross revenue was due to the type of cabinets purchased by the client. We incurred operating expenses of $6,897 and $60,487 for the nine months ended April 30, ~~2018 and 2017~~2025, ~~respectively. These expenses consisted of general operating expenses, including professional fees, incurred in connection with~~ the ~~day~~Company toissued ~~day operation of our business and the preparation and filing of our periodic reports. For the year nine months ended April 30~~4, ~~2017 we also incurred $38~~185,~~700~~000 inshares ~~private label development fees. An income tax provision~~ of ~~$404~~common ~~was~~stock ~~recorded~~ for ~~the nine months ended April 30, 2018. An income tax provision of~~ $541,~~881~~850 ~~was recorded for April 30, 2017~~cash.

11NOTE 8 – SUBSEQUENT EVENTS

OnIn ~~July~~accordance ~~17,~~with ~~2015~~ASC Topic 855-10, wethe ~~issued~~Company ~~4,000,000~~has ~~shares~~analyzed ofits ~~common~~operations ~~stock~~subsequent to ~~our~~April ~~sole~~30, ~~officer~~2025 ~~and~~to ~~director.~~the ~~Mr.~~date ~~Augustin~~these ~~purchased~~financial ~~the~~statements ~~4,000,000~~were ~~shares~~available atto abe ~~purchase~~issued ~~price~~and ofhas ~~$0.001~~determined ~~per~~that ~~share,~~it ~~for~~does annot ~~aggregate~~have ~~purchase~~any ~~price~~material ofsubsequent ~~$4,000~~events to disclose in these financial statements.

~~The~~13 ~~company’s~~Table ~~Registration Statement on Form S-1 was declared effective on October 6, 2016. In October 2016 the company sold 1,015,000 shares~~ of ~~common stock to 31 independent shareholders at a price of $0.04 per share for total proceeds of $40,600, pursuant to the Registration Statement.~~Contents

~~Our~~Item ~~company~~2. ~~had~~Management’s ~~5,015,000~~Discussion ~~shares of common stock issued~~ and ~~outstanding~~Analysis as of ~~April~~Financial ~~30,~~Conditions ~~2018. During 2015, Stanislav Augustin, our sole officer~~ and ~~director~~Results ~~advanced the Company $100 to pay expenses. The loan is an oral contract, bears no interest and is payable on demand. As~~ of ~~April 30, 2018, the company had no accounts receivable, no accounts payable and $100 in a loan payable~~Operations.

~~The~~FORWARD-LOOKING ~~following table provides selected financial data about our company for the period ended April 30, 2018. For detailed financial information, see the financial statements included in this report.~~STATEMENTS

Balance Sheet Data:	4/30/2018
Cash	$	486
Total assets	$	15,836
Total liabilities	$	100
Stockholder’s equity	$	15,736

The following discussion may contain forward-looking statements regarding the Company, its business prospects and its results of operations that are subject to certain risks and uncertainties posed by many factors and events that could cause the Company’s actual business, prospects and results of operations to differ materially from those that may be anticipated by such forward-looking statements. These forward-looking statements reflect our view only as of the date of this report. The Company cannot guarantee future results, levels of activity, performance, or achievement. The Company does not undertake any obligation to update or correct any forward-looking statements.

WeResults ~~are~~of ~~actively~~Operations ~~working~~for tothe ~~advance~~three ~~our~~months ~~business~~ended ~~plan.~~April ~~We have generated $373~~30,~~139~~ in2025 ~~revenue~~and ~~since inception.~~2024

Our 12 month plan of operation includes developing our US business including establishing a sales force team to sell more file cabinet products. If we are able to justify the expense we will buy a small US office and will start US business operations from it, servicing our US clients. Until then we will continue to operate from the Czech Republic office we already have. Revenues

~~Our~~We ~~initial~~earned ~~focus~~no isrevenues ~~expansion~~for ~~into~~three ~~the~~months USended ~~market.~~April ~~The Czech operations will only be expanded once we have sufficient funds from our US operations~~30, ~~which~~2025 ~~Management~~or ~~estimates to be in 3-5 years~~2024.

~~Liquidity~~Operating ~~and Capital Resources~~Expenses

~~Our~~We ~~assets~~incurred at$60,453 ~~April~~in ~~30,~~operating ~~2018~~expenses ~~were~~for ~~$15,836~~the ~~which~~three ~~included~~months ~~$486~~ended inApril ~~cash~~30, 2025, as compared with $560,~~190~~272 in ~~income~~the ~~tax~~three ~~benefit~~months ~~and~~ended ~~$10~~April 30,~~160~~ ~~(net)~~2024. The increase in ~~our~~operating ~~office~~expenses ~~building.~~is ~~Management~~the ~~estimates~~result ~~our~~increased ~~current~~general ~~monthly~~and ~~“burn~~administrative ~~rate”~~fees toduring bethe $5three months ended April 30,~~000~~ 2025. We expect our operating expenses will ~~require~~increase ~~additional~~in ~~revenues~~future oryears ~~loans~~as ~~from~~a ~~our~~result ~~director~~of tothe ~~continue~~costs ~~operations.~~associated with the increased operating activity under our business model.

12Other Income/Expenses

~~Off-Balance~~We ~~Sheet~~had ~~Arrangements~~other expenses of $5,310 for the three months ended April 30, 2025, compared to other expenses of $3,590 for the three months ended April 30, 2024. The increase in other expenses was the result of increased interest expense associated with additional debt incurred during the three months ended April 30, 2025.

WeNet do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.Loss

~~ITEM~~We 4recorded a net loss of $65,763 for the three months ended April 30, 2025, compared to a net loss $63,862 for the three months ended April 30, 2024. ~~CONTROLS~~The ~~AND~~decrease ~~PROCEDURES~~in net loss was associated with the factors discussed above.

~~Evaluation~~14 Table of ~~Disclosure Controls and Procedures~~Contents

~~Management~~ Results ~~maintains “disclosure controls and procedures,” as such term is defined in Rule 13a-15(e) under the Securities Exchange Act~~ of ~~1934~~Operations ~~(the~~for ~~“Exchange Act”), that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within~~ the ~~time~~nine ~~periods~~months ~~specified~~ended inApril ~~the Securities and Exchange Commission rules and forms~~30, ~~and~~2025 ~~that such information is accumulated~~ and ~~communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.~~2024

In connection with the preparation of this quarterly report on Form 10-Q, an evaluation was carried out by management, with the participation of the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of April 30, 2018.Revenues

~~Based~~We onearned ~~that~~no ~~evaluation,~~revenues ~~management~~for ~~concluded,~~nine asmonths ofended ~~the~~April ~~end of the period covered by this report~~30, ~~that~~2025 ~~our~~or disclosure controls and procedures were effective in recording, processing, summarizing, and reporting information required to be disclosed, within the time periods specified in the Securities and Exchange Commission’s rules and forms2024.

~~Changes~~Operating ~~in Internal Controls over Financial Reporting~~Expenses

AsWe ofincurred ~~the~~$145,921 ~~end~~in ofoperating expenses for the ~~period~~nine ~~covered~~months byended ~~this~~April ~~report~~30, ~~there~~2025, ~~have~~as ~~been~~compared nowith ~~changes~~$126,398 in the ~~internal~~nine ~~controls~~months ~~over~~ended ~~financial~~April ~~reporting~~30, 2024. The increase in operating expenses is the result increased in professional fees during the ~~quarter~~nine months ended April 30, ~~2018,~~2025. ~~that~~We ~~materially~~expect ~~affected,~~our oroperating ~~are~~expenses ~~reasonably~~will ~~likely~~increase toin ~~materially~~future ~~affect,~~years ~~our~~as ~~internal~~a ~~control~~result ~~over~~of ~~financial~~the ~~reporting~~costs ~~subsequent~~associated towith the ~~date~~increased ofoperating ~~management’s~~activity ~~last~~under ~~evaluation~~our business model.

13Other Income/Expenses

~~PART~~We IIhad other expenses of $15,171 for the nine months ended April 30, 2025, compared to other expenses of $10,943 for the nine months ended April 30, 2024. The increase in other expenses was the result of increased interest expense associated with additional debt incurred during the nine months ended April 30, 2025.

~~OTHER~~Net ~~INFORMATION~~Loss

~~ITEM~~We 1recorded a net loss of $161,092 for the nine months ended April 30, 2025, compared to a net loss $137,341 for the nine months ended April 30, 2024. ~~LEGAL~~The ~~PROCEEDINGS~~decrease in net loss was associated with the factors discussed above.

~~Our~~Going Company is not involved in any material litigation and we are unaware of any threatened material litigation. However, the cabinet industry has had litigation regarding trademarks, patents and other intellectual property rights. In addition, from time to time, we may become involved in litigation relating to claims arising from the ordinary course of our business.Concern

~~ITEM~~The 1Aaccompanying financial statements have been prepared in US dollars and in accordance with accounting principles generally accepted in the United States (“GAAP”) on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. During ~~RISK~~the ~~FACTORS~~nine months ended April 30, 2025, the Company incurred net losses of $161,092, accumulated deficits of $5,598,390, and used cash in operations in the amount of $116,550. These conditions raise substantial doubt about the Company's ability to continue as a going concern.

~~Not~~We are entirely dependent on our ability to attract and receive funding from either the sale of securities or outside sources such as private investment or a strategic partner. We currently have no firm agreements or arrangements with respect to any such financing and there can be no assurance that any needed funds will be available to us on acceptable terms or at all. The inability to obtain sufficient funding of our operations in the future will restrict our ability to grow and reduce our ability to continue to conduct business operations. Our failure to raise additional funds will adversely affect our business, and may require us to suspend our operations, which in turn may result in a loss to the purchasers of our common stock. If we are unable to obtain necessary financing, we will likely be required ~~under~~to ~~Regulation~~curtail ~~S-K~~our ~~for~~development ~~“smaller~~plans. ~~reporting~~Any ~~companies~~additional equity financing may involve substantial dilution to our then existing stockholders.”

~~ITEM~~15 2.Table ~~UNREGISTERED~~of ~~SALES OF EQUITY SECURITIES AND USE OF PROCEEDS~~Contents

~~None.~~Liquidity and Capital Resources

~~ITEM~~Our 3.financing ~~DEFAULTS~~objective ~~UPON~~is ~~SENIOR~~to ~~SECURITIES~~maintain financial flexibility to meet the material, equipment and personnel needs to support our project commitments, and pursue our expansion and diversification objectives.

~~There~~As ~~were~~of noApril ~~defaults~~30, ~~upon~~2025, ~~senior~~we ~~securities~~had ~~during~~total ~~the~~current ~~period~~assets ~~ended~~of $584 and total current liabilities of $403,125. We had a working capital deficit of $402,541 as of April 30, ~~2018~~2025.

~~ITEM~~Net 4cash used by operating activities was $116,550 for the nine months ended April 30, 2025, as compared with $88,187 cash used for the nine months ended April 30, 2024. ~~MINE~~Our ~~SAFETY~~negative ~~DISCLOSURES~~operating cash flow for both periods was our net losses, as adjusted to reconcile net loss to net cash provided by operating activities.

~~Not~~Financing ~~applicable~~activities provided $117,134 in cash for the nine months ended April 30, 2025, as compared with $88,187 for the nine months ended April 30, 2024. The increase in cash provided by financing activities was the result of proceeds provided through the issuance of common stock during the nine months ended April 30, 2025.

~~ITEM~~16 5.Table ~~OTHER~~of ~~INFORMATION~~Contents

~~None~~Item 3. Quantitative and Qualitative Disclosures about Market Risk

14As a smaller reporting company, we are not required to provide the information required by this Item.

ITEM 64. ~~EXHIBITS~~CONTROLS AND PROCEDURES

~~The~~Management’s ~~following~~Responsibility ~~exhibits~~for ~~are~~Controls ~~included with this quarterly filing. Those marked with an asterisk~~ and required to be filed hereunder, are incorporated by reference and can be found in their entirety in our Registration Statement on Form S-1, filed under SEC File Number 333-208934, at the SEC website at www.sec.gov:Procedures

Exhibit No.		Description
3.1		Articles of Incorporation*
3.2		Bylaws*
31		Sec. 302 Certification of Chief Executive Officer & Chief Financial Officer
32		Sec. 906 Certification of Principal Executive Officer & Principal Financial Officer
101		Interactive data files pursuant to Rule 405 of Regulation S-T

The Company’s management is responsible for establishing and maintaining adequate internal control over the Company’s financial reporting. The Company’s controls over financial reporting are designed under the supervision of the Company’s Principal Executive Officer and Principal Financial Officer to ensure that information required to be disclosed by the Company in the reports that the Company files or submits under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is accumulated and communicated to the Company’s management, including the Company’s principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

15Evaluation of Disclosure Controls and Procedures

~~SIGNATURES~~Under the supervision and with the participation of our Principal Executive Officer and Chief Financial Officer, the Company conducted an evaluation of the effectiveness of the design and operation of its disclosure controls and procedures, as such term is defined under Rule 13a-15(e) promulgated under the Exchange Act, as of April 30, 2025. Based on this evaluation, management concluded that our financial disclosure controls and procedures were not effective so as to timely record, process, summarize and report financial information required to be included on our SEC reports due to the Company’s limited internal resources and lack of ability to have multiple levels of transaction review. However, as a result of our evaluation and review process, management believes that the financial statements and other information presented herewith are materially correct.

~~Pursuant~~Internal toControl ~~the~~Over ~~requirements~~Financial ~~of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on this 7th day of May, 2018.~~ Reporting

~~Reliant~~As ~~Service~~of ~~Inc~~April 30, 2025, under the supervision and with the participation of our management, we conducted an evaluation of the effectiveness of the design and operations of our internal control over financial reporting, as defined in Rules 13a-15(f) or 15d-15(f) promulgated under the Securities Exchange Act of 1934 and based on the criteria for effective internal control described in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (as revised). Based on our evaluation, ~~Registrant~~management ~~By:~~concluded /that our internal control over financial reporting was not effective so as to timely record, process, summarize and report financial information required to be included on our Securities and Exchange Commission (“SEC”) reports due to the Company’s/ ~~Stanislav~~limited ~~Augustin~~internal ~~Stanislav~~resources ~~Augustin~~and lack of ability to have multiple levels of transaction review. However, ~~CEO~~as ~~Chief~~a ~~Executive~~result ~~Officer~~of &our ~~Chief~~evaluation ~~Financial~~and ~~Officer~~review process, management believes that the financial statements and other information presented herewith are materially correct.

16The management including its Principal Executive Officer/Principal Financial Officer, does not expect that its disclosure controls and procedures, or its internal controls over financial reporting will prevent all error and all fraud. A control system no matter how well conceived and operated, can provide only reasonable not absolute assurance that the objectives of the control system are met. Further, the design of the control system must reflect the fact that there are resource constraints, and the benefit of controls must be considered relative to their costs.

Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected.

Table of Contents

The Company has limited resources and as a result, a material weakness in financial reporting currently exists, because of our limited resources and personnel, including those described below.

*	The Company has an insufficient quantity of dedicated resources and experienced personnel involved in reviewing and designing internal controls. As a result, a material misstatement of the interim and annual financial statements could occur and not be prevented or detected on a timely basis.

*	We have not achieved the optimal level of segregation of duties relative to key financial reporting functions.

*	We do not have an audit committee or an independent audit committee financial expert. While not being legally obligated to have an audit committee or independent audit committee financial expert, it is management’s view that to have an audit committee, comprised of independent board members, and an independent audit committee financial expert is an important entity-level control over the Company’s financial statements.

A material weakness is a deficiency (within the meaning of the Public Company Accounting Oversight Board (PCAOB) auditing standard 5) or combination of deficiencies in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. Management has determined that a material weakness exists due to a lack of segregation of duties, resulting from the Company’s limited resources and personnel.

Remediation Efforts to Address Deficiencies in Internal Control Over Financial Reporting

As a result of these findings, management, upon obtaining sufficient capital and operations, intends to take practical, cost-effective steps in implementing internal controls, including the possible remedial measures set forth below. As of April 30, 2025, we did not have sufficient capital and/or operations to implement any of the remedial measures described below.

*	Assessing the current duties of existing personnel and consultants, assigning additional duties to existing personnel and consultants, and, in a cost effective manner, potentially hiring additional personnel to assist with the preparation of the Company’s financial statements to allow for proper segregation of duties, as well as additional resources for control documentation.

*	Assessing the duties of the existing officers of the Company and, in a cost effective manner, possibly promote or hire additional personnel to diversify duties and responsibilities of such executive officers.

*	Board to review and make recommendations to shareholders concerning the composition of the Board of Directors, with particular focus on issues of independence. The Board of Directors will consider nominating an audit committee and audit committee financial expert, which may or may not consist of independent members.

*	Interviewing and potentially hiring outside consultants that are experts in designing internal controls over financial reporting based on criteria established in Internal Control Integrated Framework issued by Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) (as revised).

(b) Change in Internal Control Over Financial Reporting

The Company has not made any change in our internal control over financial reporting during the period ended April 30, 2025.

Table of Contents

PART II. OTHER INFORMATION

Item 1. Legal Proceedings.

We are not party to any material legal proceedings. From time to time, we may be involved in legal proceedings or subject to claims incident to the ordinary course of business. The outcome of litigation is inherently uncertain, and there can be no assurances that favorable outcomes will be obtained. In addition, regardless of the outcome, such proceedings or claims can have an adverse impact on us, which may be material because of defense and settlement costs, diversion of resources and other factors.

Item 1A. Risk Factors.

The risks described under the heading “Risk Factors” in our Factors that could cause or contribute to such differences may include, but are not limited to, those described under the heading “Risk Factors” which are included in the Company’s Registration Statement on Form 10, as amended, which was previously filed with the Securities and Exchange Commission. The risks and uncertainties described therein are not the only ones we face. Additional risks and uncertainties that we are unaware of or that we currently deem immaterial may also become important factors that adversely affect our business.

You should carefully read and consider such risks, together with all of the other information in our Registration Statement on Form 10 and in this Quarterly Report on Form 10-Q (including the disclosures in the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and in our condensed consolidated financial statements and related notes), and in the other documents that we file with the SEC.

There have been no material changes from the risk factors previously disclosed under the heading “Risk Factors” in our Registration Statement on Form 10, as amended.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

(a) None.

(b) Not applicable.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not Applicable.

Item 5. Other Information.

None

Table of Contents

ITEM 6 - EXHIBITS

Number Description of Exhibit

3.1		Articles of Incorporation, as amended*
3.2		Amended Certificate of Designation filed February 20, 2024, with the Nevada Secretary of State**
3.3		Bylaws*
31.1		Certification of Principal Executive Officer and Principal Financial Officer Pursuant to Rule 13A-14(A) Under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.***
32.1		Certification pursuant to Securities Exchange Act of 1934 Rule 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002. ***

	*	Previously Filed as part of the Company’s Registration Statement on Form 1-A, specifically as exhibits to the Part II-Offering Circular thereto, originally filed with the SEC on February 29, 2024.

	**	Previously Filed as part of the Company's Registration Statement on Form 10 filed with the SEC on February 3, 2025.

	***	Filed herewith

	#	The XBRL related information in Exhibit 101 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section and shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Quantumzyme Corp.

Date: June 20, 2025	By:	/s/ Naveen Krishnarao Kulkarni
	Name:	Naveen Krishnarao Kulkarni
	Title:	Chief Executive Officer & Chief Financial Officer

Filing Compare · Quantum Genesis AI Corp.